Why OrganiGram (TSXV:OGI) Might Have the Best Strategy for the Edibles Market

OrganiGram Holdings Inc (TSXV:OGI) is hoping that a big investment in chocolate will produce sweet returns for the company when edibles launch later this year.

| More on:
Profit dial turned up to maximum

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

We’re fewer than five months away from the legalization of cannabis edibles. Companies are ramping up production, and we’ve seen various types of strategies deployed by marijuana companies looking to take advantage of this new segment of the market.

There have been some high-profile partnerships and investments being made, particularly with beverage companies and marijuana stocks. OrganiGram Holdings (TSXV:OGI) is taking a different approach. Rather than focusing on beverages, it’s looking to chocolate to help grab a significant share of the edibles market.

The company recently announced a $15 million investment in a product line that will help it produce as much as four million kilograms of cannabis chocolate annually. It’s expected to be ready by the fall and could make OrganiGram a big player in the industry. We know how popular chocolate is with cannabis customers, and in the U.S. it has proven to be more popular than beverages.

However, we haven’t seen Canadian cannabis companies show significant interest in chocolate since a lot of the hype has been around beverages. And that’s where OrganiGram could slice out a big part of the segment by having what it calls a “high-speed, high-capacity, fully automated” product line. At a price tag of just $15 million, it’s also much more economical than investing in beverages would likely be, and it’s a segment that may or may not prove to be significant.

Beverages have a lot of potential in being able to offer consumers a buzz without a hangover, but it’s still a bit of an unknown how much demand there might be for cannabis-infused beverages. They will, after all, be competing alongside alcoholic drinks that many consumers already have a strong taste for. Chocolate, meanwhile, we know is a hit with consumers, and adding some CBD or THC to it without negatively impacting the taste could make it an easy sell for cannabis enthusiasts.

Aurora doesn’t see the hype in beverages

One company that isn’t sold on beverages is Aurora Cannabis (TSX:ACB)(NYSE:ACB), at least not yet. Despite the attention that the company has received lately about some key personnel it added to the mix, it may not be because Aurora is in search of a deal with a beverage maker.

Chief Corporate Officer Cam Battley recently told investors, “We’ve made a rational decision to focus priorities in areas that we know have strong demand based on a model we’ve seen in legal U.S. states.” This is alluding to the low market share that beverages have made up in edibles and suggests that perhaps like OrganiGram, Aurora will be focusing on chocolate or other edible products.

The concern I see is that unlike big players in the industry, we haven’t seen much movement from Aurora when it comes to edibles. While it may very well be doing it on its own with the need for a big acquisition or investment, it’s a strategy that’s a bit odd for a company that hasn’t been shy in the past when it comes to making a splash and acquiring a big company.

We’ll soon find out whether its approach pays off or if beverages prove to be the next big thing in the industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »